miércoles, 10 de diciembre de 2014

Palabras: "budget-busting drugs"

 


"Sovaldi, the first of the so called 
budget-busting’ drugs. 

The hepatitis C treatment’s $84,000 list price..."





"budget-busting drugs"

Que revientan presupuestos...

Evaluatepharma Budget-Busters
 Click sobre imagen para ampliar

"Sovaldi and other high-priced drugs such as Lucentis, an eye medication made by Genentech that can cost as much as $2,000 per dose, are part of an expected wave of breakthroughs in new, expensive pharmaceutical treatments for a variety of diseases and chronic conditions." (Ver)


The price of Gilead Sciences' breakthrough drug Sovaldi has drawn all of the attention this year. By pricing it at $85,000 for a 12-week course, Gilead Sciences has been pilloried by politicians, payers and providers. But as EvaluatePharma points out, at that price Sovaldi barely makes it into the top 20 most expensive drugs, number 19 to be exact, just above Novartis' Gleevec and just below GlaxoSmithKline's Mekinist. Sovaldi is pricey, but if you want to talk about really pricey, then look at the 10 most expensive. The least of those, Celgene's Revlimid, ran $128,666 last year, the numbers ninjas at EvaluatePharma determined. The most expensive, Soliris, costs nearly $537,000.(Más)


Ver también:

ROCHE: Con Kadcyla al "Club de los $1.000 day"

Novartis & Roche: De res Aviditatis (Codicia)...Avastin & Lucentis

Huérfano y biotecnológico, perfil de los medicamentos más caros

Publicar un comentario en la entrada